Mimedx Q1 2026 non-GAAP EPS -$0.07 (-240% YoY) misses, revenue $59.0M (-33% YoY), cuts 2026 guidance to $260–$290M with breakeven adjusted EBITDA
https://finviz.com/quote?t=MDXG&p=d
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.